PRPH - ProPhase Company Long-Term Debts

Graphic logo of ProPhase Labs Corp (PRPH)

The market trend for ProPhase Labs, Inc. (PRPH) demonstrates long-term debt dynamics, which currently stand at 0.00. The business is vulnerable to trade conflicts and supply chain disruptions of Asian components. The company generates revenue from the sale of genetic tests and dietary supplements to US government agencies and private individuals. Strictly regulated express delivery routes for essential reagents ensure operational stability.

PRPH ProPhase Labs, Inc.: Company Long-Term Debts in the range 07/04/2022 - 01/10/2026

Financial and market metric breakdowns for ProPhase (PRPH)

- price and consensus price forecast:
Share Price prophaselabs.com|PRPH - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization ProPhase Labs|PRPH - Total Company Value
- book capitalization data:
Equity per Share ProPhase Labs|PRPH - Book Capitalization|Market Capitalization to Book Value Ratio prophaselabs.com|PRPH - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity ProPhase Labs, Inc.|PRPH - Long-Term Debt to Equity Ratio|Current Liabilities to Capital ProPhase Labs Corp|PRPH - Company Debts|Debts to Net Assets ProPhase Labs|PRPH - Company Long-Term Debts|Short-Term Debt Volume ProPhase Labs
General company analysis:PRPH (prophaselabs.com)
Mass-produced product of ProPhase Labs

Portfolio managers evaluate the operating model of ProPhase Labs, Inc. (PRPH) through the lens of long-term liabilities, which measure the aggregate of loans and borrowings with maturities exceeding one year to analyze capital stability. By examining the history of the corporation's long-term loans and borrowings, investors can see how the debt load correlates with the costs of expensive CLIA certification, confirming the financial strength of the issuer's position.

Competing companies

Company Long-Term Indebtedness agilent.com A|Quest Diagnostics Incorporated - Company Long-Term Debts|ILMN: Company Long-Term Debts|Company Long-Term Debt Cologuard|Revvity Corp (RVTY) - Company Long-Term Indebtedness|BIO (Bio-Rad Laboratories) - Company Long-Term Debts|Company Long-Term Debts NNNN|Company Long-Term Debt Sotera Health (SHC)|Company Long-Term Debt Quidel Corporation QDEL|OPK: Company Long-Term Liabilities|CareDx - Long-Term Debt|Company Long-Term Debt MRVI (Maravai LifeSciences)|FLGT - Long-Term Debt Volume|Standard BioTools - Company Long-Term Debts|CTKB (Cytek Biosciences Inc) - Long-Term Debt Volume|OSUR: Company Long-Term Debt|Long-Term Debt Volume XGN|MDXH - Company Long-Term Debt|Long-Term Liabilities LUCD (luciddx.com)|Company Long-Term Debt Prenetics|Insight Molecular Diagnostics, Inc. - Company Long-Term Loans and Borrowings|TRIB (Trinity Biotech Corp) - Company Long-Term Debt|AIMD: Long-Term Debt|Company Long-Term Debt Co-Diagnostics, Inc. (CODX)|heartsciences.com (HSCS) - Long-Term Liabilities|BMRA - Company Long-Term Debts|Company Long-Term Loans and Borrowings Cardio Diagnostics Holdings, Inc.|Company Long-Term Debts VRAX|Company Long-Term Debts BJDX (Bluejay Diagnostics Corp)|Company Long-Term Debt AWH|Long-Term Debt Volume acceleratediagnostics.com AXDX|CNTG (CENTOGENE) - Company Long-Term Debts|Enzo Biochem, Inc. (ENZ) - Long-Term Debt|Company Long-Term Liabilities fresh2.co FRES|GENE (Genetic Technologies Limited) - Company Long-Term Loans and Borrowings|Company Long-Term Debt 23andMe Holding Co.|Company Long-Term Debt psychemedics.com